A proud milestone for GENNVAX at Africa Health Excon 2025.

This week, we took another major step toward vaccine sovereignty in Egypt and Africa.

From signing our landmark contract with Vacsera, to hosting an impactful GENNVAX session alongside Africa CDC, the Ambassadors of India and Denmark, and our global technology transfer partners — this moment reflects the power of collaboration, vision, and purpose. With a portofolio of 26 vaccines mostly locally manufactured I believe we are witnessing history in the making.

Deep thanks to UPA and its exceptional leadership, as well as the EVMA Vaccines Group, for their tireless efforts in driving forward vaccine localization across the continent.

Together, we’re not just building a facility — we’re building resilience, equity, and health security for generations to come.

The Egyptian Authority for Unified Procurement “UPA” Zydus Group AJ Vaccines Africa Health ExCon Africa CDC Gennecs Pharmaceuticals Adam ElDaba